BeyondSpring, Inc. (BYSI) Q4 2020 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to BeyondSpring's fourth quarter and full year 2020 financial results conference call. At this time, all participants are in listen-only mode. Following management's prepared remarks, we will hold a brief question and answer session. To join the question queue, you may press star then 1 on your telephone keypad. Should you need assistance during the conference call, you may signal an operator by pressing star and 0. As a reminder, this call is being recorded today, April 30th, 2021. I would now like to turn the conference over to Andrew Erickson, Investor Relations. Please go ahead. Thank you, everyone, for joining today's call. I'd like to advise listeners that comments made on today's call may reflect forward-looking statements that are related to such matters as BeyondSpring's clinical and preclinical research and development activities and results. regulatory and commercial plans, industry trends, market potential, collaborative initiatives, and financial projections, among others. While management believes that assumptions, expectations, and projections are reasonable in view of the currently available information, we are cautioned not to place undue reliance on these forward-looking statements. The company's actual results may differ materially from those discussed during this call for a variety of reasons. including those described in the forward-looking statements and risk factors sections of the company's 20F and other filings with the SEC, which are available on the investor section of BeyondSpring's website. Joining us on today's call is Dr. Lan Huang, BeyondSpring co-founder, chairwoman, and chief executive officer, Dr. Ramon Mohanla, executive vice president, research and development, and chief medical officer, Richard Daly, chie...